2025 年 DNA 定序全球市場報告

預計未來幾年DNA定序市場規模將快速成長。到 2029 年，這一數字將成長至 291.6 億美元，複合年成長率為 16.5%。預測期內的成長可歸因於次世代定序(NGS)、群體定序、群體基因體學工作、人工智慧和機器學習的整合以及精準醫療的採用等方面的進步。預測期內的關鍵趨勢包括單細胞定序的進展、表觀遺傳學和轉錄組學的重點、液態切片的發展、道德和隱私考慮以及奈米技術的整合。

預計未來幾年癌症發生率的上升將推動 DNA 定序市場的成長。癌症的特徵是細胞不受控制地增殖，影響各個器官並導致世界範圍內的嚴重發病率和死亡率。 DNA定序對於識別基因突變、了解腫瘤生物學和確定治療結果至關重要，從而改善癌症治療結果。例如，2024年1月，專注於癌症宣傳的美國非營利組織美國癌症協會報告稱，癌症患者數量從2023年的1,958,310人增加到2,001,140人，增幅為2.19%。因此，癌症發生率的上升正在推動 DNA 定序市場的成長。

此外，個人化醫療日益成長的需求預計也將在未來幾年推動 DNA 定序市場的成長。個人化醫療是一種創新的醫療保健方法，它考慮到患者基因、環境和生活方式的個體差異。個人化醫療（根據個人基因特徵制定治療方案）受到的關注日益增加，這推動了對 DNA 定序技術的需求，以識別特定的基因突變並指導治療決策。例如，2024年2月，美國非營利組織個人化醫療聯盟報告稱，FDA已核准16種針對罕見疾病患者的新的個人化治療方法（而2022年只有6種）。因此，個人化醫療的需求不斷成長，正在推動DNA定序市場的未來成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球 DNA 序列 PESTEL 分析（政治、社會、科技、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球 DNA 定序市場：成長率分析
• 全球 DNA 定序市場表現：規模與成長，2019 年至 2024 年
• 全球 DNA 定序市場預測：規模與成長，2024-2029 年，2034 年
• 全球 DNA 定序總目標市場 (TAM)

第6章 市場細分

• 全球 DNA 定序市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 裝置
• 耗材
• 服務
• 全球 DNA 定序市場（依技術、效能和預測）2019-2024 年、2024-2029 年、2034 年
• 第三代 DNA 定序
• 次世代定序
• 桑格定序
• 全球 DNA 定序市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 診斷
• 生物標記和癌症
• 生殖健康
• 個人化醫療
• 法醫學
• 其他用途
• 全球 DNA 定序市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院和醫療機構
• 學術及研究機構
• 製藥和生物技術公司
• 其他最終用戶
• 全球 DNA 定序市場、儀器細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 次世代定序(NGS) 系統
• 桑格定序系統
• 單分子定序儀
• 全球 DNA 定序市場依耗材類型細分，實際狀況及預測，2019-2024 年、2024-2029 年、2034 年
• 試劑
• 套件
• 晶片和流動池
• 全球 DNA 定序市場，依服務類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 定序服務
• 資料分析服務
• 生物資訊服務

第7章 區域和國家分析

• 全球 DNA 定序市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球 DNA 定序市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• DNA 定序市場：競爭格局
• DNA 定序市場：公司簡介
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Siemens Healthineers AG
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• BGI Genomics
• Myriad Genetics Inc.
• Natera Inc.
• 10x Genomics Inc.
• GenScript Biotech Corporation
• Novogene Corporation
• Twist Bioscience
• Genewiz LLC

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年 DNA 定序市場：提供新機會的國家
• 2029 年 DNA 定序市場：細分市場將帶來新機會
• 2029 年 DNA 定序市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

DNA sequencing involves determining the precise order or sequence of nucleotides (adenine, cytosine, guanine, and thymine) in a DNA molecule. This molecular biology and genetics technique is fundamental, enabling scientists to decipher the genetic code embedded within an organism's DNA.

The primary components of DNA sequencing are instruments, consumables, and services. Instruments, defined as mechanical tools or implements, particularly those used for delicate or precise operations, are employed in DNA sequencing to automate and execute the various steps involved in sequencing DNA samples. Technologies such as third-generation DNA sequencing, next-generation sequencing, and Sanger sequencing are applied in diagnostics, biomarkers and cancer research, reproductive health studies, personalized medicine initiatives, forensics, and other scientific domains. This technology is utilized by a diverse range of entities, including hospitals and healthcare organizations, academic and research institutions, as well as pharmaceutical and biotechnology companies.

The DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides DNA sequencing market statistics, including the DNA sequencing industry's global market size, regional shares, competitors with an DNA sequencing market share, detailed DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the DNA sequencing industry. This DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The DNA sequencing market size has grown rapidly in recent years. It will grow from $13.77 billion in 2024 to $15.84 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to human genome project, cost reduction, biomedical research expansion, clinical diagnostics adoption, pharmaceutical R&D needs

The DNA sequencing market size is expected to see rapid growth in the next few years. It will grow to $29.16 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to next-generation sequencing (NGS) advancements, point-of-care sequencing, population genomics initiatives, ai and machine learning integration, precision medicine adoption. Major trends in the forecast period include single-cell sequencing advancements, epigenetics and transcriptomics focus, liquid biopsy development, ethical and privacy considerations, integration of nanotechnology.

The rising prevalence of cancer is anticipated to drive the growth of the DNA sequencing market in the future. Cancer is characterized by uncontrolled cell proliferation, affecting various organs and leading to significant morbidity and mortality globally. DNA sequencing is essential for identifying genetic mutations, understanding tumor biology, and informing treatment decisions, resulting in better outcomes in cancer care. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported that the number of cancer cases rose to 2,001,140, up from 1,958,310 in 2023, reflecting an increase of 2.19%. Thus, the growing prevalence of cancer is propelling the growth of the DNA sequencing market.

The rising demand for personalized medicine is also expected to drive the growth of the DNA sequencing market in the coming years. Personalized medicine is an innovative healthcare approach that considers individual differences in patients' genes, environments, and lifestyles. The increasing focus on personalized medicine, which tailors treatments to an individual's genetic profile, has heightened the demand for DNA sequencing technologies to identify specific genetic variations and guide treatment decisions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to just six in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the DNA sequencing market moving forward.

An emerging trend gaining traction in the DNA sequencing market is the progress in single-cell DNA sequencing technologies. Leading companies in the market are embracing innovative technologies to maintain their competitive positions. For example, in May 2023, Mission Bio Inc., a biotechnology company based in the US, introduced Tapestri v3, an advanced version of its high-throughput single-cell DNA and multi-omics analysis platform. Tapestri v3 incorporates breakthrough improvements in chemistry, significantly enhancing the detection of rare cells across various applications. Its improved cell capture capabilities allow researchers to identify previously undetectable single cells, providing a deeper understanding of diseases. This enhanced technology is particularly promising for applications such as measurable residual disease (MRD) assessment in cancer, where Tapestri v3 enables the detection of relapse-driving clones that were previously overlooked. Additionally, it offers advantages for developers of cell and gene therapy by enabling quality assessment at the single-cell level.

Major players in the DNA sequencing market are directing their efforts towards developing innovative solutions, including production-scale sequencers. These advanced DNA sequencing machines are designed for large-scale and high-throughput sequencing, facilitating the efficient processing of significant volumes of genetic material in research, clinical, or industrial settings. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the 'NovaSeq X Series,' a new production-scale sequencer capable of sequencing more than 20,000 genomes per year with the highest levels of accuracy. This sustainable high-throughput sequencer achieves a 90% reduction in packaging, a 50% reduction in plastic waste, and eliminates the need for dry ice shipments, enhancing global access to genomic medicine and demonstrating a commitment to environmental responsibility.

In March 2024, Clinical Microbiomics, a contract research organization based in Denmark, acquired DNASense ApS for an undisclosed amount. This acquisition is intended to enhance Clinical Microbiomics' capabilities in long-read DNA and RNA sequencing, allowing for a deeper understanding of microbiome complexities and speeding up discoveries in microbiome and metabolome analysis. DNASense ApS is a Denmark-based microbiome CRO specializing in long-read DNA and RNA sequencing technologies.

Major companies operating in the DNA sequencing market include F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

North America was the largest region in the DNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the DNA sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The DNA sequencing market consists of revenues earned by entities by providing bioinformatics and data analysis software and sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA sequencing market also includes sales of DNA sequencing kits, sequencing reagents, and laboratory equipment used in providing DNA sequencing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments; Consumables; Services
• 2) By Technology: Third Generation DNA Sequencing; Next-Generation Sequencing; Sanger Sequencing
• 3) By Application: Diagnostics; Biomarkers And Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
• 4) By End User: Hospitals And Healthcare Organizations; Academics And Research Institutions; Pharmaceutical And Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Single-Molecule Sequencing Instruments
• 2) By Consumables: Reagents; Kits; Chips And Flow Cells
• 3) By Services: Sequencing Services; Data Analysis Services; Bioinformatics Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Sequencing Market Characteristics

3. DNA Sequencing Market Trends And Strategies

4. DNA Sequencing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global DNA Sequencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global DNA Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global DNA Sequencing Market Growth Rate Analysis
• 5.4. Global DNA Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global DNA Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global DNA Sequencing Total Addressable Market (TAM)

6. DNA Sequencing Market Segmentation

• 6.1. Global DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Consumables
• Services
• 6.2. Global DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Third Generation DNA Sequencing
• Next-Generation Sequencing
• Sanger Sequencing
• 6.3. Global DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Biomarkers And Cancer
• Reproductive Health
• Personalized Medicine
• Forensics
• Other Applications
• 6.4. Global DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Healthcare Organizations
• Academics And Research Institutions
• Pharmaceutical And Biotechnology Companies
• Other End Users
• 6.5. Global DNA Sequencing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS) Systems
• Sanger Sequencing Systems
• Single-Molecule Sequencing Instruments
• 6.6. Global DNA Sequencing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents
• Kits
• Chips And Flow Cells
• 6.7. Global DNA Sequencing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing Services
• Data Analysis Services
• Bioinformatics Services

7. DNA Sequencing Market Regional And Country Analysis

• 7.1. Global DNA Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global DNA Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA Sequencing Market

• 8.1. Asia-Pacific DNA Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA Sequencing Market

• 9.1. China DNA Sequencing Market Overview
• 9.2. China DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA Sequencing Market

• 10.1. India DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA Sequencing Market

• 11.1. Japan DNA Sequencing Market Overview
• 11.2. Japan DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA Sequencing Market

• 12.1. Australia DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA Sequencing Market

• 13.1. Indonesia DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA Sequencing Market

• 14.1. South Korea DNA Sequencing Market Overview
• 14.2. South Korea DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA Sequencing Market

• 15.1. Western Europe DNA Sequencing Market Overview
• 15.2. Western Europe DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA Sequencing Market

• 16.1. UK DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA Sequencing Market

• 17.1. Germany DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA Sequencing Market

• 18.1. France DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA Sequencing Market

• 19.1. Italy DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA Sequencing Market

• 20.1. Spain DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA Sequencing Market

• 21.1. Eastern Europe DNA Sequencing Market Overview
• 21.2. Eastern Europe DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA Sequencing Market

• 22.1. Russia DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA Sequencing Market

• 23.1. North America DNA Sequencing Market Overview
• 23.2. North America DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA Sequencing Market

• 24.1. USA DNA Sequencing Market Overview
• 24.2. USA DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA Sequencing Market

• 25.1. Canada DNA Sequencing Market Overview
• 25.2. Canada DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA Sequencing Market

• 26.1. South America DNA Sequencing Market Overview
• 26.2. South America DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA Sequencing Market

• 27.1. Brazil DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA Sequencing Market

• 28.1. Middle East DNA Sequencing Market Overview
• 28.2. Middle East DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA Sequencing Market

• 29.1. Africa DNA Sequencing Market Overview
• 29.2. Africa DNA Sequencing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa DNA Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA Sequencing Market Competitive Landscape And Company Profiles

• 30.1. DNA Sequencing Market Competitive Landscape
• 30.2. DNA Sequencing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. DNA Sequencing Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers AG
• 31.2. Eurofins Scientific SE
• 31.3. Agilent Technologies Inc.
• 31.4. Illumina Inc.
• 31.5. PerkinElmer Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. QIAGEN N.V.
• 31.8. BGI Genomics
• 31.9. Myriad Genetics Inc.
• 31.10. Natera Inc.
• 31.11. 10x Genomics Inc.
• 31.12. GenScript Biotech Corporation
• 31.13. Novogene Corporation
• 31.14. Twist Bioscience
• 31.15. Genewiz LLC

32. Global DNA Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA Sequencing Market

34. Recent Developments In The DNA Sequencing Market

35. DNA Sequencing Market High Potential Countries, Segments and Strategies

• 35.1 DNA Sequencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 DNA Sequencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 DNA Sequencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer